CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (48,194)	$ (115,727)	$ (72,105)	$ (97,838)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization			34,360	37,909
Deferred income taxes			(18,764)	(44,809)
Equity in net loss of equity-method investees	966	528	2,371	1,226
Stock-based compensation, net	3,017	3,228	10,135	10,657
Intangibles and long-lived asset impairment	49,426	156,583	70,786	156,923
Loss (gain) on sale of assets			62	(3,529)
Other non-cash items, net			944	(1,526)
(Decrease) increase in cash attributable to changes in operating assets and liabilities:
Accounts receivable			(30,672)	(7,926)
Inventories			27,432	(8,534)
Other current assets			13,830	455
Other assets and liabilities			(4,466)	3,496
Accounts payable and accrued expenses			43,046	(20,195)
Net cash provided by operating activities			76,959	26,309
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment			(24,769)	(21,434)
Investments and joint ventures, net			0	433
Proceeds from sale of assets			1,520	7,758
Net cash used in investing activities			(23,249)	(13,243)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility			152,000	275,000
Repayments under bank revolving credit facility			(197,000)	(301,000)
Repayments under term loan			(5,625)	(5,625)
Payments of other debt, net			(3,875)	(2,116)
Employee shares withheld for taxes			(1,600)	(1,051)
Net cash used in financing activities			(56,100)	(34,792)
Effect of exchange rate changes on cash			(1,425)	(104)
Net decrease in cash and cash equivalents			(3,815)	(21,830)
Cash and cash equivalents at beginning of period	53,364	65,512
Cash and cash equivalents at end of period	$ 49,549	$ 43,682	$ 49,549	$ 43,682